Unveiling the role of astrocyte-derived LCN2 in neurodegenerative disease progression Post author: Post published:October 4, 2023 Post category:uncategorized Researchers reviewed existing data on the neurodegenerative effects of astrocyte-derived lipocalin-2 (LCN-2). You Might Also Like Two diabetes medications more beneficial in preventing major cardiovascular events June 3, 2024 Study finds growing divide in Swedish healthcare utilization by income November 16, 2023 Why children with Down’s syndrome are predisposed to developing leukaemia September 26, 2024